Drupal.behaviors.print = function(context) {window.print();window.close();}>
LabCorp Licenses Sequella Technology for TB Assay Development
October 22, 2012
LabCorp Licenses Sequella Technology for TB Assay Development
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Trovagene Licenses Leukemia Marker to Quest Diagnostics
September 13, 2012 / GenomeWeb Daily News
Bankruptcy Court OKs Correlogic Motion to 'Reject' Quest, LabCorp Pacts
October 7, 2010 / GenomeWeb Daily News
Merck, LabCorp in PGx Licensing Deal
July 28, 2010 / GenomeWeb Daily News
Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx
May 22, 2013 / GenomeWeb Daily News
GenomeDx, Mayo Clinic Expand Research Deal
April 29, 2013 / GenomeWeb Daily News